StonvexLoading…
StonvexStonvexStonvexCore line items from SHLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $158.72M | $140.56M | $475.33M | $327.01M | $191.20M |
Operating Income | Not available | $7.72M | $56.38M | $38.98M | $20.31M |
Net Income | Not available | $-297.00K | $33.57M | $25.45M | $13.86M |
EPS (Diluted) | $0.10 | $0.00 | $0.20 | $0.15 | $0.08 |
Total Assets | Not available | $1.03B | $904.10M | $851.79M | $794.96M |
Total Liabilities | Not available | $429.25M | $304.13M | $262.15M | $219.56M |
Cash & Equivalents | Not available | $1.88M | $7.32M | $8.59M | $4.69M |
Free Cash Flow OCF − CapEx | Not available | $-49.10M | $-15.98M | $-4.72M | $-13.69M |
Shares Outstanding | Not available | 167.56M | 168.38M | 167.72M | 167.24M |